[Hypertriglyceridemias].
Triglyceride atherogenicity is still a matter of controversy for reasons related to their biological and epidemiological characteristics. The authors discuss and review several of these problems, as well as the metabolic relationship of triglycerides and HDL-cholesterol, data indicating a strong influence of triglycerides on cardiovascular risk, mechanisms mediating the pathogenicity of triglycerides, and some questions of drug treatment of hypertriglyceridemias.
Silva
J M
JM
Serviço de Medicina II-HUC.
Méndez
M M
MM
Devesa
N
N
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D015228:Hypertriglyceridemia / Q000150:complications* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood*
D000960:Hypolipidemic Agents; D014280:Triglycerides
Hipertrigliceridemias.